Adaptive Trials in the Neoadjuvant Setting: A Model to Safely Tailor Care While Accelerating Drug Development
Year: 2012
Type: article
Source: Journal of Clinical Oncology
Authors: Douglas Yee, Tufia Haddad, Kathy Albain, Anna Barker, Christopher Benz, Judy Boughey, Meredith Buxton, Amy Jo Chien, Angela DeMichele, David Dilts, Anthony Elias, Paul Haluska, Michael Hogarth, Alan Hu, Nola Hytlon, Henry G. Kaplan, Gary G. Kelloff, Qamar Khan, Julie Lang, Brian Leyland-Jones, Minetta Liu, Rita Nanda, Donald Northfelt, Olufunmilayo I. Olopade, John Park, Barbara Parker, David Parkinson, Sonia Pearson-White, Jane Perlmutter, Lajos Pusztai, Fraser Symmans, Hope Rugo, Debu Tripathy, Anne Wallace, David Wholley, Laura van't Veer, Donald A. Berry, Laura Esserman
Institutions: University of Minnesota, Masonic Cancer Center, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Loyola University Chicago, Loyola Medicine, Quantum Leap Healthcare Collaborative, Arizona State University, Buck Institute for Research on Aging, University of California, San Francisco, Abramson Cancer Center, University of Pennsylvania, Oregon Health & Science University, University of Colorado Boulder, University of California, Davis, National Institutes of Health, National Cancer Institute, The University of Kansas Cancer Center, University of Kansas Medical Center, University of Arizona, University of Arizona Cancer Center, Sanford Health, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of Chicago, Mayo Clinic in Arizona, University of California San Diego, Moores Cancer Center, Nodality (United States), Foundation for the National Institutes of Health, The University of Texas MD Anderson Cancer Center, University of Southern California, USC Norris Comprehensive Cancer Center
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2064044903